Microglial reactivity and neuroinflammation-driven changes in motivational behaviors are regulated by Orai1 calcium
Kaitlyn E DeMeulenaere1, Rogan A Grant2, Megan E Martin1
1Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Abstract:
Microglia are the brain's resident immune cells that respond to injury and disease by transitioning between homeostatic and reactive states. These cell state transitions determine whether microglia promote or resolve inflammation in the central nervous system (CNS). In this study, we explored the role of Ca2+ signaling in regulating broader microglial cell state transitions and identified Orai1 Ca2+ channels as critical regulators of microglial plasticity and neuroinflammatory signaling. Conditional deletion of Orai1 in microglia impaired their ability to adopt reactive, proinflammatory states. Transcriptomic and metabolomic profiling revealed that Orai1 deletion suppressed the expression of proinflammatory genes linked to immunity, inflammation, and cell metabolism. Conversely, Orai1-deficient microglia generated greater amounts of neuroprotective and anti-inflammatory mediators, including BDNF, ARG1, and the mitochondrial metabolite itaconate. In a model of CNS inflammation induced by peripheral lipopolysaccharide (LPS) challenge, microglial Orai1 deletion attenuated microglial and astrocyte reactivity and reduced hippocampal amounts of the proinflammatory cytokines IL-1β and IL-6. Consistent with these cellular changes, microglial Orai1 knockout mice were protected against LPS-induced decreases in motivational behaviors, including impaired reward-seeking and escape behaviors. These findings establish Orai1 channels as key regulators of microglial cell state transitions, linking Ca2+ signaling to neuroinflammation and inflammation-driven behavioral dysfunction.
Insights
Orai1 calcium channels regulate microglial cell states, impacting neuroinflammation. Deleting Orai1 in microglia reduces inflammation and protects against behavioral deficits in models of central nervous system (CNS) disease.
Area of Science:
- Neuroimmunology
- Cellular Neuroscience
- Calcium Signaling
Background:
- Microglia, the brain's immune cells, shift states to control central nervous system (CNS) inflammation.
- Cell state transitions are crucial for determining inflammatory outcomes in the CNS.
- Calcium (Ca2+) signaling plays a role in regulating microglial responses.
Purpose of the Study:
- To investigate the role of Ca2+ signaling in microglial cell state transitions.
- To identify specific Ca2+ channels involved in regulating microglial plasticity and neuroinflammation.
- To determine the functional consequences of modulating these channels on microglial responses and behavior.
Main Methods:
- Conditional deletion of Orai1 channels in microglia.
- Transcriptomic and metabolomic profiling of Orai1-deficient microglia.
- In vivo models of CNS inflammation (lipopolysaccharide challenge).
- Assessment of microglial and astrocyte reactivity.
- Behavioral testing in knockout mice.
Main Results:
- Orai1 deletion in microglia impaired their transition to reactive, pro-inflammatory states.
- Orai1 deficiency suppressed pro-inflammatory gene expression and enhanced neuroprotective mediator production (e.g., BDNF, ARG1, itaconate).
- Microglial Orai1 knockout attenuated neuroinflammation and protected against behavioral deficits in an LPS-induced inflammation model.
Conclusions:
- Orai1 Ca2+ channels are critical regulators of microglial cell state plasticity.
- Orai1 links Ca2+ signaling to neuroinflammatory pathways and behavior.
- Targeting Orai1 may offer a therapeutic strategy for neuroinflammatory and behavioral disorders.
More Related Videos
10:40Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
Published on: October 27, 2019
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
